109 related articles for article (PubMed ID: 29558701)
1. Predicting pharmacy syringe sales to people who inject drugs: Policy, practice and perceptions.
Meyerson BE; Davis A; Agley JD; Shannon DJ; Lawrence CA; Ryder PT; Ritchie K; Gassman R
Int J Drug Policy; 2018 Jun; 56():46-53. PubMed ID: 29558701
[TBL] [Abstract][Full Text] [Related]
2. Pharmacist attitudes and provision of harm reduction services in North Carolina: an exploratory study.
Parry RA; Zule WA; Hurt CB; Evon DM; Rhea SK; Carpenter DM
Harm Reduct J; 2021 Jul; 18(1):70. PubMed ID: 34238306
[TBL] [Abstract][Full Text] [Related]
3. Examining the effects of COVID-19 on pharmacy dispensing of naloxone and syringes sales across Massachusetts and New Hampshire.
Bolivar D; Hartung D; Silcox J; Bratberg J; Boggis J; Rabin M; Green TC
J Am Pharm Assoc (2003); 2023; 63(1):330-335.e1. PubMed ID: 36369076
[TBL] [Abstract][Full Text] [Related]
4. ASAP: A pharmacy-level intervention to increase nonprescription syringe sales to reduce bloodborne illnesses.
Meyerson BE; Agley J; Crosby RA; Bentele KG; Vadiei N; Linde-Krieger LB; Russell DR; Fine K; Eldridge LA
Res Social Adm Pharm; 2024 Aug; 20(8):778-785. PubMed ID: 38734511
[TBL] [Abstract][Full Text] [Related]
5. Attitudes, beliefs, knowledge, and practices for over-the-counter syringe sales in community pharmacies: A systematic review.
Gionfriddo MR; Owens KM; Leist SE; Schrum LT; Covvey JR
J Am Pharm Assoc (2003); 2023; 63(5):1472-1489.e3. PubMed ID: 37429389
[TBL] [Abstract][Full Text] [Related]
6. Internalized stigma and sterile syringe use among people who inject drugs in New York City, 2010-2012.
Rivera AV; DeCuir J; Crawford ND; Amesty S; Lewis CF
Drug Alcohol Depend; 2014 Nov; 144():259-64. PubMed ID: 25307745
[TBL] [Abstract][Full Text] [Related]
7. "I go out of my way to give them an extra smile now:" A study of pharmacists who participated in Respond to Prevent, a community pharmacy intervention to accelerate provision of harm reduction materials.
Irwin AN; Gray M; Ventricelli D; Boggis JS; Bratberg J; Floyd AS; Silcox J; Hartung DM; Green TC
Res Social Adm Pharm; 2024 May; 20(5):512-519. PubMed ID: 38395644
[TBL] [Abstract][Full Text] [Related]
8. Readiness of community pharmacies to implement an opioid safety intervention.
Floyd AS; Silcox J; Cousin E; Irwin AN; Gray M; Bolivar D; Bratberg J; Arnold J; Al-Jammali Z; Hansen RN; Hartung DM; Green TC
J Am Pharm Assoc (2003); 2023; 63(1):275-283.e1. PubMed ID: 36496310
[TBL] [Abstract][Full Text] [Related]
9. Over-the-counter antibiotic sales in community and online pharmacies, China.
Gong Y; Jiang N; Chen Z; Wang J; Zhang J; Feng J; Lu Z; Yin X
Bull World Health Organ; 2020 Jul; 98(7):449-457. PubMed ID: 32742030
[TBL] [Abstract][Full Text] [Related]
10. Tobacco sales in pharmacies: time to quit.
Hudmon KS; Fenlon CM; Corelli RL; Prokhorov AV; Schroeder SA
Tob Control; 2006 Feb; 15(1):35-8. PubMed ID: 16436403
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with perceived ease of access to syringes in Appalachian North Carolina.
Carpenter DM; Zule WA; Hennessy CM; Evon DM; Hurt CB; Ostrach B
J Rural Health; 2023 Jan; 39(1):212-222. PubMed ID: 35819251
[TBL] [Abstract][Full Text] [Related]
12. The Cost of Safe Injection: Insights on Nonprescription Syringe Price Variability From Systematic Secret Shopping.
Blough MJ; Rocha A; Bratberg J; Silcox J; Bolivar D; Floyd AS; Gray M; Green TC
Subst Use Addctn J; 2024 Apr; 45(2):201-210. PubMed ID: 38258818
[TBL] [Abstract][Full Text] [Related]
13. Rural Community Pharmacy Approaches to Lethal Means Management for Suicide Prevention.
Lavigne J; West J; Carpenter D
Clin Gerontol; 2024; 47(4):594-606. PubMed ID: 37551694
[TBL] [Abstract][Full Text] [Related]
14. Pharmacy staff-reported adaptations to naloxone provision and over-the-counter (OTC) syringe sales during the COVID-19 pandemic: Experiences across multiple states and 2 pharmacy chains.
Green TC; Silcox J; Bolivar D; Gray M; Floyd AS; Irwin AN; Hansen RN; Hartung DM; Bratberg J
J Am Pharm Assoc (2003); 2024; 64(1):71-78. PubMed ID: 37863398
[TBL] [Abstract][Full Text] [Related]
15. Pharmacy staff characteristics associated with support for pharmacy-based HIV testing.
Amesty S; Blaney S; Crawford ND; Rivera AV; Fuller C
J Am Pharm Assoc (2003); 2012; 52(4):472-9, 1-9. PubMed ID: 22825227
[TBL] [Abstract][Full Text] [Related]
16. Innovating the Model for Student Pharmacists to Increase Access to Hepatitis C Testing (Project IMPACT).
Januszka J; Notarianni V; Devenny E; Harris E
J Am Pharm Assoc (2003); 2023; 63(4):1217-1221. PubMed ID: 37037394
[TBL] [Abstract][Full Text] [Related]
17. Injection Behaviors and Use of Syringe Service Programs over Time among People Who Inject Drugs in Baltimore, Maryland.
German D; Glick JL; Yenokyan K; Genberg B; Sawyer A; Gribbin M; Flynn C
Subst Use Misuse; 2024; 59(5):651-664. PubMed ID: 38115628
[No Abstract] [Full Text] [Related]
18. Trends and correlates of naloxone possession and use among people who inject drugs in Seattle, Washington.
Zinsli KA; Banta-Green CJ; Whiteside LK; Hood J; Kingston S; Tinsley J; Moreno C; Glick SN
Int J Drug Policy; 2023 Dec; ():104272. PubMed ID: 38057247
[TBL] [Abstract][Full Text] [Related]
19. Spatial inequities in access to medications for treatment of opioid use disorder highlight scarcity of methadone providers under counterfactual scenarios.
Tatara E; Lin Q; Ozik J; Kolak M; Collier N; Halpern D; Anselin L; Dahari H; Boodram B; Schneider J
medRxiv; 2023 Nov; ():. PubMed ID: 37292847
[TBL] [Abstract][Full Text] [Related]
20. Detection of drugs and hepatitis C virus in used syringes from a needle exchange in Gothenburg, Sweden.
Bergström MA; Andersson ME; Larsson SB
Drug Test Anal; 2023 Dec; ():. PubMed ID: 38044807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
